Literature DB >> 3190737

Location and characterization of the warfarin binding site of human serum albumin. A comparative study of two large fragments.

O J Bos1, J P Remijn, M J Fischer, J Wilting, L H Janssen.   

Abstract

The warfarin binding behaviour of a large tryptic fragment (residues 198-585 which comprise domains two and three) and of a large peptic fragment (residues 1-387 which comprise domains one and two) of human serum albumin has been studied by circular dichroism and equilibrium dialysis in order to locate and characterize the primary warfarin binding site. The induced ellipticity of the warfarin-peptic fragment complex turned out to be pH dependent. This pH dependence occurs in the region of the neutral-to-base transition of the albumin molecule. The induced ellipticity of the warfarin-tryptic fragment complex is pH independent. Difference CD-spectra showed that the peptic fragment and albumin have similar warfarin binding properties whereas the tryptic fragment has deviant warfarin binding properties. The equilibrium dialysis experiments showed that the affinity of warfarin to the peptic fragment and to albumin is practically the same whereas the affinity of warfarin to the tryptic fragment is a factor 2-8 lower than the affinity of warfarin to albumin. Our results indicate that the main part of the primary warfarin binding site is located in domain two of the albumin structure and that domain one plays an important role in the N-B transition of albumin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190737     DOI: 10.1016/0006-2952(88)90072-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Bioactivity of albumins bound to silver nanoparticles.

Authors:  Jessy Mariam; S Sivakami; D C Kothari; P M Dongre
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

2.  Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.

Authors:  M Dockal; M Chang; D C Carter; F Rüker
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

3.  Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains.

Authors:  Da Shi; Yin-xiu Jin; Yi-hong Tang; Hai-hong Hu; Si-yun Xu; Lu-shan Yu; Hui-di Jiang; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2012-05       Impact factor: 6.150

4.  Effect of common buffers and heterocyclic ligands on the binding of Cu(II) at the multimetal binding site in human serum albumin.

Authors:  Magdalena Sokołowska; Krystyna Pawlas; Wojciech Bal
Journal:  Bioinorg Chem Appl       Date:  2010-05-05       Impact factor: 7.778

5.  Thermodynamics, conformation and active sites of the binding of Zn-Nd hetero-bimetallic Schiff base to bovine serum albumin.

Authors:  Qi Xiao; Shan Huang; Yi Liu; Fang-fang Tian; Jun-cheng Zhu
Journal:  J Fluoresc       Date:  2008-10-21       Impact factor: 2.217

6.  A point mutation in the human serum albumin gene results in familial dysalbuminaemic hyperthyroxinaemia.

Authors:  C E Petersen; A G Scottolini; L R Cody; M Mandel; N Reimer; N V Bhagavan
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

Review 7.  Interactive association of drugs binding to human serum albumin.

Authors:  Feng Yang; Yao Zhang; Hong Liang
Journal:  Int J Mol Sci       Date:  2014-02-27       Impact factor: 5.923

8.  Investigation of human albumin-induced circular dichroism in dansylglycine.

Authors:  Fernanda S Graciani; Valdecir F Ximenes
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.